bioAffinity Technologies Inc. Warrant

Company Profile

bioAffinity Technologies Inc. Warrant had its IPO on 2022-09-01 under the ticker symbol BIAFW.

The company operates in the Healthcare sector and Diagnostics & Research industry. bioAffinity Technologies Inc. Warrant has a staff strength of 14 employees.

Stock update

Shares of bioAffinity Technologies Inc. Warrant opened at $0.21 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.21 - $0.21, and closed at $0.21.

This is a -27.59% slip from the previous day's closing price.

A total volume of 1,010 shares were traded at the close of the day’s session.

In the last one week, shares of bioAffinity Technologies Inc. Warrant have increased by 0%.

bioAffinity Technologies Inc. Warrant's Key Ratios

bioAffinity Technologies Inc. Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months bioAffinity Technologies Inc. Warrant’s revenue was $1306 with a gross profit of $0 and an EBITDA of $-2593144. The EBITDA ratio measures bioAffinity Technologies Inc. Warrant's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, bioAffinity Technologies Inc. Warrant’s operating margin was -198867.37% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, bioAffinity Technologies Inc. Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

bioAffinity Technologies Inc. Warrant’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into bioAffinity Technologies Inc. Warrant’s profitability.

bioAffinity Technologies Inc. Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

bioAffinity Technologies Inc. Warrant stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$10.46 million

Total Liabilities

$796303.00

Operating Cash Flow

$0

Capital Expenditure

$32314

Dividend Payout Ratio

0%

bioAffinity Technologies Inc. Warrant ended 2024 with $10.46 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.46 million while shareholder equity stood at $9.67 million.

bioAffinity Technologies Inc. Warrant ended 2024 with $0 in deferred long-term liabilities, $796303.00 in other current liabilities, 59241.00 in common stock, $-38200258.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9.77 million and cash and short-term investments were $9.77 million. The company’s total short-term debt was $168,430 while long-term debt stood at $0.

bioAffinity Technologies Inc. Warrant’s total current assets stands at $10.23 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $11027.00 compared to accounts payable of $146537.00 and inventory worth $11335.00.

In 2024, bioAffinity Technologies Inc. Warrant's operating cash flow was $0 while its capital expenditure stood at $32314.

Comparatively, bioAffinity Technologies Inc. Warrant paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.21

52-Week High

$4.5

52-Week Low

$0.0311

Analyst Target Price

$

bioAffinity Technologies Inc. Warrant stock is currently trading at $0.21 per share. It touched a 52-week high of $4.5 and a 52-week low of $4.5. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.34 and 200-day moving average was $0.38 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.